Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way.
about
Butyric acid-induced T-cell apoptosis is mediated by caspase-8 and -9 activation in a Fas-independent mannerChronic vascular toxicity of doxorubicin in an organ-cultured arteryCladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondriaDoxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calciumIntracellular triggering of Fas, independently of FasL, as a new mechanism of antitumor ether lipid-induced apoptosis.Detection of doxorubicin-induced apoptosis of leukemic T-lymphocytes by laser tweezers Raman spectroscopy.Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.Induction of apoptosis in human mitogen-activated peripheral blood T-lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system.Multimodality imaging of tumor response to doxilPhosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitroIonizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy.Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progressionMechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracilInterleukin-4 distinctively modifies responses of germinal centre-like and activated B-cell-like diffuse large B-cell lymphomas to immuno-chemotherapyDoxorubicin-induced death in tumour cells and cardiomyocytes: is autophagy the key to improving future clinical outcomes?Cytotoxicity of rhein, the active metabolite of sennoside laxatives, is reduced by multidrug resistance-associated protein 1Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.A FRET-based dual-targeting theranostic chimeric peptide for tumor therapy and real-time apoptosis imaging.Increased HoxB4 Inhibits Apoptotic Cell Death in Pro-B Cells.Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid.Actin cytoskeleton reorganization correlates with cofilin nuclear expression and ultrastructural changes in cho aa8 cell line after apoptosis and mitotic catastrophe induction by doxorubicin.Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon-alpha in human myeloma cells.Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients.Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis.Transforming growth factor beta induces caspase 3-independent cleavage of alphaII-spectrin (alpha-fodrin) coincident with apoptosis.Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis.Inhibitory Effects of Bangladeshi Medicinal Plant Extracts on Interactions between Transcription Factors and Target DNA Sequences.alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.Anticancer efficacy of a novel propofol-linoleic acid-loaded escheriosomal formulation against murine hepatocellular carcinoma.Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.Differentiation of promyelocytic leukaemia: alterations in Fas (CD95/Apo-1) and Fas ligand (CD178) expression.Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
P2860
Q28359805-84CA1F18-A444-43AE-AD00-2FDA7A08B571Q28361159-D71F3D2F-D997-4E42-904B-BAFBEEA5F08BQ28362384-BE99A8D6-2E47-46E6-BDCC-0D418AEF5439Q28579647-C368353C-1C35-4116-8B72-2DC5C1D4FB16Q30647113-F86ABF1D-08FE-4E54-8474-5A40880C13EFQ33801017-D38DE258-46D2-4815-BCDC-7E6981731881Q33845577-CC3E84E3-02BD-4D28-B76F-305EDF96C7ADQ35029006-63659933-6142-49F7-A392-597ADBACCE4DQ35113876-4327FCC9-E7E3-4400-8F8F-BFAAA04C6BD3Q35849100-005A5B4D-4F80-48D6-8048-14C527663F5DQ36375843-477DBAD5-4F66-483F-975A-7C02DC046E98Q36615251-F0CED38E-8A57-4B0F-9FC1-8359452441FEQ36671725-E2C0C6CE-BD39-4C26-8C87-02668C95FCA2Q37389788-85D546C0-E92C-41C8-ADF7-DF3616908EFDQ38150426-28052A82-DAE9-461A-9482-296187A1B9C7Q38283206-43FA234A-A89B-40E5-B364-75A10B3081D8Q38719813-95BD6960-3A2D-42DF-B81E-6C3C213365FEQ39007998-EEF70E48-D0F9-4AF8-BEA2-8329C59F64C8Q39292451-8F794015-E9AC-4E33-97E6-B552B1A476C2Q39562387-85FCC7A2-9B72-46CE-9CD7-2C9387110854Q39591818-397CF38F-5B19-419B-995C-C2BF3E258783Q40358490-4E916FC1-0819-4FCC-B3B7-BD2B285B0A85Q40599806-B0B9C90F-FF2D-4554-9664-50BCE9854208Q40925734-BEAD4E9E-EE94-4C6D-AED7-210D4B17DBB7Q40937155-7749A259-422F-46E7-8EEC-DF8E663C4C48Q42196578-796CE185-B44A-4173-8F03-54CE6A43937CQ42427086-6DC2E218-F7CB-48D8-B526-B65F3C2FCCEEQ42480711-1995C009-0803-47C0-8005-C3DA741B4998Q43512157-395FD09B-9974-4638-AF35-313D72E27514Q43847020-7589CE00-2FE5-432D-B7BE-1659E13B39A5Q43936447-E1F43D40-130E-4157-87FA-3CAE1CEAF4D0Q46487455-82A7BD2A-5521-4A1F-A0AA-D592F9F241B4
P2860
Doxorubicin-induced apoptosis in human T-cell leukemia is mediated by caspase-3 activation in a Fas-independent way.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Doxorubicin-induced apoptosis ...... tion in a Fas-independent way.
@en
type
label
Doxorubicin-induced apoptosis ...... tion in a Fas-independent way.
@en
prefLabel
Doxorubicin-induced apoptosis ...... tion in a Fas-independent way.
@en
P2093
P2860
P1433
P1476
Doxorubicin-induced apoptosis ...... tion in a Fas-independent way.
@en
P2093
Lasierra P
Martinez-Lorenzo MJ
P2860
P304
P356
10.1016/S0014-5793(97)01282-9
P407
P577
1997-11-01T00:00:00Z